Details for New Drug Application (NDA): 021341
✉ Email this page to a colleague
The generic ingredient in BEXTRA is valdecoxib. Additional details are available on the valdecoxib profile page.
Summary for 021341
Tradename: | BEXTRA |
Applicant: | Gd Searle |
Ingredient: | valdecoxib |
Patents: | 0 |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
Approval Date: | Nov 16, 2001 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 20MG | ||||
Approval Date: | Nov 16, 2001 | TE: | RLD: | No |
Expired US Patents for NDA 021341
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Gd Searle | BEXTRA | valdecoxib | TABLET;ORAL | 021341-002 | Nov 16, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Gd Searle | BEXTRA | valdecoxib | TABLET;ORAL | 021341-003 | Nov 16, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Gd Searle | BEXTRA | valdecoxib | TABLET;ORAL | 021341-003 | Nov 16, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Gd Searle | BEXTRA | valdecoxib | TABLET;ORAL | 021341-002 | Nov 16, 2001 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription